ARQT - Arcutis Biotherapeutics GAAP EPS of -$0.73 beats by $0.15 revenue of $38.1M beats by $7.28M
2023-11-03 07:43:22 ET
More on Arcutis Biotherapeutics
- Mizuho cuts Articus to neutral, cites lower-than-expected prescriptions
- Arcutis announces pricing of $100 million public offering
- Seeking Alpha’s Quant Rating on Arcutis Biotherapeutics
For further details see:
Arcutis Biotherapeutics GAAP EPS of -$0.73 beats by $0.15, revenue of $38.1M beats by $7.28M